首页 | 本学科首页   官方微博 | 高级检索  
   检索      

一种KBMA炭疽疫苗候选株的研制
引用本文:沈非,袁盛凌,展德文,王艳春,任敏,陶好霞,王芃,王令春,陈冬生,刘纯杰.一种KBMA炭疽疫苗候选株的研制[J].生物工程学报,2011,27(5):781-789.
作者姓名:沈非  袁盛凌  展德文  王艳春  任敏  陶好霞  王芃  王令春  陈冬生  刘纯杰
作者单位:1. 安徽师范大学生命科学学院,芜湖,241000;中国人民解放军军事医学科学院,生物工程研究所,病原微生物与生物安全国家重点实验室,北京,100071
2. 中国人民解放军军事医学科学院,生物工程研究所,病原微生物与生物安全国家重点实验室,北京,100071
3. 安徽师范大学生命科学学院,芜湖,241000
基金项目:十一五国家重大传染病专项 (No. 2008ZX10004-105) 资助。
摘    要:炭疽病是由炭疽芽胞杆菌Bacillus anthracis引起的一种人畜共患传染病,严重影响着人类的健康。近年来在细菌疫苗的研究中发现一种特殊的现象:细菌被杀死后,体内的代谢活性却仍然维持 (Killed but metabolically active,KBMA)。此发现为炭疽新型疫苗候选株的研制提供了新思路。先通过同源重组的方法,利用pMAD质粒和Cre-loxP重组酶系统完成对缺失两个毒性大质粒的炭疽芽胞杆菌减毒株AP422的uvrAB基因的敲除,得到AP422△uvrAB菌株,然后通过光化学处理 (包括长波紫外光的照射和8-甲氧基补骨脂素处理),使炭疽芽胞杆菌AP422△uvrAB失去繁殖能力。利用四氮唑化合物MTS检测其代谢活性,表明光化学处理杀死后的炭疽芽胞杆菌AP422△uvrAB在至少4 h内维持一个很高的代谢活性水平,即具备典型的KBMA特性。炭疽杆菌AP422 △uvrAB的KBMA菌株的成功研制为我们提供了一种新型炭疽疫苗候选株。

关 键 词:uvrAB基因,同源重组,Cre-LoxP系统,基因敲除,长波紫外光,8-MOP,MTS,代谢活性
收稿时间:2010/12/13 0:00:00

Development of a killed but metabolically active anthracis vaccine candidate strain
Fei Shen,Shengling Yuan,Dewen Zhan,Yanchun Wang,Min Ren,Haoxia Tao,Peng Wang,Lingchun Wang,Dongsheng Chen and Chunjie Liu.Development of a killed but metabolically active anthracis vaccine candidate strain[J].Chinese Journal of Biotechnology,2011,27(5):781-789.
Authors:Fei Shen  Shengling Yuan  Dewen Zhan  Yanchun Wang  Min Ren  Haoxia Tao  Peng Wang  Lingchun Wang  Dongsheng Chen and Chunjie Liu
Institution:College of Life Sciences, Anhui Normal University, Wuhu 241000, China; State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;College of Life Sciences, Anhui Normal University, Wuhu 241000, China; State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China;College of Life Sciences, Anhui Normal University, Wuhu 241000, China;State Key Laboratory of Pathogen and Biosafety, Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
Abstract:Anthrax is a zoonosis caused by Bacillus anthracis,which seriously affects human health.In recent years,a special phenomenon is found that the metabolic active of a bacterium remains after it is killed.To development of a KBMA(killed but metabolically active) Bacillus anthracis vaccine candidate strain,a plasmid pMAD and a recombinase system Cre-loxP were used to knockout the uvrAB gene of B.anthracis AP422 which lacks both of two plasmids pXO1 and pXO2.The results of PCR and 782 ISSN1000-3061 CN11-1998/Q C...
Keywords:uvrAB genes  homologous recombination  Cre-LoxP system  gene knockout  long-wave-length ultraviolet (UVA)  8-MOP  MTS  metabolically active
本文献已被 CNKI 万方数据 PubMed 等数据库收录!
点击此处可从《生物工程学报》浏览原始摘要信息
点击此处可从《生物工程学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号